Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct Mechanisms-Reference-Cited by-同舟云学术

Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct Mechanisms

Published:2016-10-20 Issue:2 Volume:32 Page:360-372
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Chandra Abhishek¹,Lin Tiao²¹,Young Tiffany¹,Tong Wei¹³,Ma Xiaoyuan¹,Tseng Wei-Ju¹,Kramer Ina⁴,Kneissel Michaela⁴,Levine Michael A⁵⁶,Zhang Yejia¹⁷,Cengel Keith⁸,Liu X. Sherry¹,Qin Ling¹

Affiliation:

1. Department of Orthopaedic Surgery, Perelman School of Medicine; University of Pennsylvania; Philadelphia PA USA

2. Musculoskeletal Oncology Center; The First Affiliated Hospital of Sun Yat-Sen University; Guangzhou China

3. Department of Orthopaedic Surgery; Union Hospital, Tongji Medical College; Huazhong University of Science and Technology; Wuhan Hubei China

4. Musculoskeletal Disease Area; Novartis Institutes for BioMedical Research; Basel Switzerland

5. Department of Pediatrics; Perelman School of Medicine; University of Pennsylvania; Philadelphia PA USA

6. Division of Endocrinology and Diabetes and the Center for Bone Health; The Children's Hospital of Philadelphia; Philadelphia PA USA

7. Philadelphia Veterans Affairs Medical Center and Department of Physical Medicine and Rehabilitation; Perelman School of Medicine; University of Pennsylvania; Philadelphia PA USA

8. Department of Radiation Oncology; Perelman School of Medicine; University of Pennsylvania; Philadelphia PA USA

Funder

National Institutes of Health

National Institute of Child Health and Human Development

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference54 articles.

1. Induction of cell death by radiotherapy;Ross;Endocr Relat Cancer,1999

2. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines;Delaney;Cancer,2005

3. Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models;Chargari;Cancer Metastasis Rev,2016